KZA 0.00% 8.0¢ kazia therapeutics limited

that link shows completion not until the end of the year...

  1. 25 Posts.
    lightbulb Created with Sketch. 1
    that link shows completion not until the end of the year

    mce-anchorStudy Design

    Go to


    Study Type : Interventional (Clinical Trial)
    1 Estimated Enrollment : 60 participants
    2 Intervention Model: Single Group Assignment
    3 Masking: None (Open Label)
    4 Primary Purpose: Treatment
    5 Official Title: Phase I Study of Intra-peritoneal Cantrixil in Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
    6 Study Start Date : November 2016
    7 Estimated Primary Completion Date : October 2018
    8 Estimated Study Completion Date : December 2018

    Re
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.